Ugur Sahin

Ugur Sahin was the founder of Ganymed Pharmaceuticals AG, holding the title of Chief Medical Officer from 2009 to 2010, founded in 2001.
Dr. Sahin is the founder of BioNTech SE, holding the title of Chief Executive Officer since 2008, founded in 2008.
Dr. Sahin was the founder of TRON - Translationale Onkologie an der Universitätsmedizin der, holding the title of Co-Managing Director from 2010 to 2019, founded in 2010.
Dr. Sahin is also the founder of Ci3 Management UG.
Dr. Sahin's current jobs include Chairman-Scientific Management Board at Helmholtz Institute For Translational Oncology, Managing Director at Medine GmbH since 2011, Managing Director at reSano GmbH since 2018, Co-Managing Director at BioNTech Delivery Technologies GmbH, and Professor at Universitätsmedizin der Johannes Gutenberg-Universität Mainz since 2014.
Dr. Sahin's education includes a doctorate from Universität zu Köln, conferred in 1990.